Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Zofran (ondansetron) is commonly prescribed off-label for severe nausea and vomiting in pregnancy, including hyperemesis gravidarum, and most large studies have not shown a clear increase in overall birth defects, though some research has raised questions about small risks such as cleft palate or heart defects with first-trimester use. Timing matters, since the first trimester is when organ development occurs, and many clinicians reserve ondansetron for cases where vitamin B6, doxylamine, or other first-line options have not worked. Dosage, route, personal heart rhythm history, and how severe your symptoms are all influence whether the benefits outweigh the uncertainties, so there are several important factors to consider before deciding. See below for the complete answer, including what the evidence does and does not establish and which alternatives are usually tried first.
If you are weighing nausea medication during pregnancy or your symptoms feel more intense than typical morning sickness, a free, instant, online symptom check can help you organize what you are experiencing and clarify whether you need prompt care or a conversation with your obstetric provider about safer options.
Last reviewed for medical accuracy: 10/22/2026
Nausea and vomiting affect up to 80% of pregnant people. When simple measures (diet changes, rest, vitamin B6) fall short, some clinicians turn to Zofran (ondansetron). Here’s an evidence-based look at what we know about using Zofran in pregnancy—its safety profile, timing considerations, and practical tips—so you can make an informed decision with your healthcare provider.
Before considering Zofran, providers often recommend:
If symptoms don’t improve after 1–2 weeks of first-line measures—or if dehydration develops—talk with your clinician about whether Zofran is appropriate.
For non-urgent concerns, you might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always consult your healthcare provider before starting, stopping, or changing any medication during pregnancy.
Deciding on Zofran in pregnancy involves balancing the relief of debilitating nausea against a small potential risk of birth defects. The bulk of evidence shows that when first-line options fail, ondansetron can be a reasonable next step. Be proactive: track your symptoms, ask questions, and partner with your doctor to choose the safest path for you and your baby.
(References)
* Oliveira L, Capp S. In reply. Obstet Gynecol. 2015 Feb;125(2):491. doi: 10.1097/AOG.0000000000000651. PMID: 25611628.
* Sumikura H. Do fetuses need vasopressors just before their birth? J Anesth. 2018 Aug;32(4):481-482. doi: 10.1007/s00540-018-2524-6. Epub 2018 Jun 21. PMID: 29931390.
* Haas DM. Helping Pregnant Women and Clinicians Understand the Risk of Ondansetron for Nausea and Vomiting During Pregnancy. JAMA. 2018 Dec 18;320(23):2425-2426. doi: 10.1001/jama.2018.19328. PMID: 30561464.
* Barnhart ML, Rosenbaum K. Anaphylactoid Syndrome of Pregnancy. Nurs Womens Health. 2019 Feb;23(1):38-48. doi: 10.1016/j.nwh.2018.11.006. PMID: 30738557.
* Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, Painter RC, Mullin PM. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019 Sep 12;5(1):62. doi: 10.1038/s41572-019-0110-3. Epub 2019 Sep 12. PMID: 31515515.
* Ekobena P, Ivanyuk A, Livio F. [Pharmacovigilance update]. Rev Med Suisse. 2021 Jan 13;17(720-1):80-84. PMID: 33443836.
* Cafri G, Wood J, Gagne J. Partition testing for real-world evidence studies. Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1280-1286. doi: 10.1002/pds.5540. Epub 2022 Sep 20. PMID: 36089808.
* Volmert B, Kiselev A, Juhong A, Wang F, Riggs A, Kostina A, O'Hern C, Muniyandi P, Wasserman A, Huang A, Lewis-Israeli Y, Panda V, Bhattacharya S, Lauver A, Park S, Qiu Z, Zhou C, Aguirre A. A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization. Nat Commun. 2023 Dec 12;14(1):8245. doi: 10.1038/s41467-023-43999-1. Epub 2023 Dec 12. PMID: 38086920; PMCID: PMC10716495.
* Nelson-Piercy C, Dean C, Shehmar M, Gadsby R, O'Hara M, Hodson K, Nana M, Royal College of Obstetricians and Gynaecologists. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69). BJOG. 2024 Jun;131(7):e1-e30. doi: 10.1111/1471-0528.17739. Epub 2024 Feb 4. PMID: 38311315.
* Nersesjan M, Nersesjan SC, Pedersen L, Christensen MB. Treatment of nausea in hospitalized patients with acute illness. Ugeskr Laeger. 2024 Apr 15;186(16). doi: 10.61409/V11230735. PMID: 38704720.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.